Inhibition of insulin release by scorpion toxin in rat pancreatic islets

David G Johnson, D. P. Henry, J. Moss, R. H. Williams

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Toxin purified from venom of the scorpion Leiurus quinquestriatus was used to release norepinephrine from adrenergic nerve terminals in isolated pancreatic islets perifused in vitro. Addition of toxin (10 μg./ml.) to the perifusion medium caused a sixfold increase in release of norepinephrine in the presence or absence of 3 x 10-5M phenoxybenzamine. During 20 minutes of stimulation with toxin, the pancreatic islets released an average of 15 pg. of norepinephrine per islet, which represented 20 percent of the normal content of norepinephrine in islets. Insulin secretory rates in response to either 1.0 or 3.0 mg./ml. glucose were inhibited similarly by scorpion toxin. Addition of phenoxybenzamine abolished the inhibition of insulin release caused by scorpion toxin. Phenoxybenzamine alone did not affect release of insulin. Neither the enhanced release of norepinephrine nor the decreased release of insulin was reversed by a 20 minute wash out period after infusion of toxin. These results indicate that the sympathetic nerve terminals in the rat pancreatic islet contain considerable amounts of norepinephrine that can be released by scorpion toxin. The norepinephrine released from sympathetic nerve endings in the pancreatic islet can inhibit release of insulin through an alpha adrenergic action that is blocked by phenoxybenzamine.

Original languageEnglish (US)
Pages (from-to)198-201
Number of pages4
JournalDiabetes
Volume25
Issue number3
StatePublished - 1976
Externally publishedYes

Fingerprint

Scorpions
Islets of Langerhans
Norepinephrine
Phenoxybenzamine
Insulin
Adrenergic Agents
Secretory Rate
Scorpion Venoms
Nerve Endings
Glucose

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Johnson, D. G., Henry, D. P., Moss, J., & Williams, R. H. (1976). Inhibition of insulin release by scorpion toxin in rat pancreatic islets. Diabetes, 25(3), 198-201.

Inhibition of insulin release by scorpion toxin in rat pancreatic islets. / Johnson, David G; Henry, D. P.; Moss, J.; Williams, R. H.

In: Diabetes, Vol. 25, No. 3, 1976, p. 198-201.

Research output: Contribution to journalArticle

Johnson, DG, Henry, DP, Moss, J & Williams, RH 1976, 'Inhibition of insulin release by scorpion toxin in rat pancreatic islets', Diabetes, vol. 25, no. 3, pp. 198-201.
Johnson, David G ; Henry, D. P. ; Moss, J. ; Williams, R. H. / Inhibition of insulin release by scorpion toxin in rat pancreatic islets. In: Diabetes. 1976 ; Vol. 25, No. 3. pp. 198-201.
@article{d24a8911d3954cf99595ed08e8f0a9ab,
title = "Inhibition of insulin release by scorpion toxin in rat pancreatic islets",
abstract = "Toxin purified from venom of the scorpion Leiurus quinquestriatus was used to release norepinephrine from adrenergic nerve terminals in isolated pancreatic islets perifused in vitro. Addition of toxin (10 μg./ml.) to the perifusion medium caused a sixfold increase in release of norepinephrine in the presence or absence of 3 x 10-5M phenoxybenzamine. During 20 minutes of stimulation with toxin, the pancreatic islets released an average of 15 pg. of norepinephrine per islet, which represented 20 percent of the normal content of norepinephrine in islets. Insulin secretory rates in response to either 1.0 or 3.0 mg./ml. glucose were inhibited similarly by scorpion toxin. Addition of phenoxybenzamine abolished the inhibition of insulin release caused by scorpion toxin. Phenoxybenzamine alone did not affect release of insulin. Neither the enhanced release of norepinephrine nor the decreased release of insulin was reversed by a 20 minute wash out period after infusion of toxin. These results indicate that the sympathetic nerve terminals in the rat pancreatic islet contain considerable amounts of norepinephrine that can be released by scorpion toxin. The norepinephrine released from sympathetic nerve endings in the pancreatic islet can inhibit release of insulin through an alpha adrenergic action that is blocked by phenoxybenzamine.",
author = "Johnson, {David G} and Henry, {D. P.} and J. Moss and Williams, {R. H.}",
year = "1976",
language = "English (US)",
volume = "25",
pages = "198--201",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Inhibition of insulin release by scorpion toxin in rat pancreatic islets

AU - Johnson, David G

AU - Henry, D. P.

AU - Moss, J.

AU - Williams, R. H.

PY - 1976

Y1 - 1976

N2 - Toxin purified from venom of the scorpion Leiurus quinquestriatus was used to release norepinephrine from adrenergic nerve terminals in isolated pancreatic islets perifused in vitro. Addition of toxin (10 μg./ml.) to the perifusion medium caused a sixfold increase in release of norepinephrine in the presence or absence of 3 x 10-5M phenoxybenzamine. During 20 minutes of stimulation with toxin, the pancreatic islets released an average of 15 pg. of norepinephrine per islet, which represented 20 percent of the normal content of norepinephrine in islets. Insulin secretory rates in response to either 1.0 or 3.0 mg./ml. glucose were inhibited similarly by scorpion toxin. Addition of phenoxybenzamine abolished the inhibition of insulin release caused by scorpion toxin. Phenoxybenzamine alone did not affect release of insulin. Neither the enhanced release of norepinephrine nor the decreased release of insulin was reversed by a 20 minute wash out period after infusion of toxin. These results indicate that the sympathetic nerve terminals in the rat pancreatic islet contain considerable amounts of norepinephrine that can be released by scorpion toxin. The norepinephrine released from sympathetic nerve endings in the pancreatic islet can inhibit release of insulin through an alpha adrenergic action that is blocked by phenoxybenzamine.

AB - Toxin purified from venom of the scorpion Leiurus quinquestriatus was used to release norepinephrine from adrenergic nerve terminals in isolated pancreatic islets perifused in vitro. Addition of toxin (10 μg./ml.) to the perifusion medium caused a sixfold increase in release of norepinephrine in the presence or absence of 3 x 10-5M phenoxybenzamine. During 20 minutes of stimulation with toxin, the pancreatic islets released an average of 15 pg. of norepinephrine per islet, which represented 20 percent of the normal content of norepinephrine in islets. Insulin secretory rates in response to either 1.0 or 3.0 mg./ml. glucose were inhibited similarly by scorpion toxin. Addition of phenoxybenzamine abolished the inhibition of insulin release caused by scorpion toxin. Phenoxybenzamine alone did not affect release of insulin. Neither the enhanced release of norepinephrine nor the decreased release of insulin was reversed by a 20 minute wash out period after infusion of toxin. These results indicate that the sympathetic nerve terminals in the rat pancreatic islet contain considerable amounts of norepinephrine that can be released by scorpion toxin. The norepinephrine released from sympathetic nerve endings in the pancreatic islet can inhibit release of insulin through an alpha adrenergic action that is blocked by phenoxybenzamine.

UR - http://www.scopus.com/inward/record.url?scp=0017105006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017105006&partnerID=8YFLogxK

M3 - Article

C2 - 767185

AN - SCOPUS:0017105006

VL - 25

SP - 198

EP - 201

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -